RiverVest Venture Partners Welcomes Brandon Cohen as Analyst

JULY 2025

RiverVest Venture Partners Welcomes Brandon Cohen as Analyst

Brandon Cohen

ST. LOUIS–(July 8, 2025)–Life sciences venture capital firm RiverVest Venture Partners is pleased to announce that Brandon Cohen has joined the firm as an analyst based in the St. Louis office.

Cohen earned a Bachelor of Science in Business Administration (BSBA) from Washington University in St. Louis, graduating in May 2025 with a double major in Accounting and Finance, and a minor in Psychological and Brain Sciences.

“RiverVest has a 25-year track record of investing in groundbreaking biopharmaceutical and medical device companies,” said Cohen. “I’m excited to contribute to the firm’s success and collaborate with such a talented team.”

In his role, Cohen will work alongside Associate Andrew Kleiboeker, Senior Analyst Jeff Seitz, and Consultant Poppy Keller to analyze portfolio company financings and M&A transactions, support operational activities across the portfolio, and assist the team in due diligence and market analysis for new investment opportunities.

“RiverVest prioritizes strong financial analysis and deep due diligence in assessing potential investment opportunities and structuring deals,” said Kleiboeker. “It’s a pleasure to welcome Brandon to the St. Louis office, and I look forward to working with him.”

“RiverVest’s strength lies in our people,” said Co-Founder and Managing Director Jay Schmelter. “Brandon will be a great addition to our strong, committed, and cohesive team. We’re thrilled to have him on board.”

About RiverVest Venture Partners

RiverVest Venture Partners is a leading venture capital firm building life science companies to address significant unmet needs of patients and deliver consistently strong returns to investors. With headquarters in St. Louis and offices in San Diego and Cleveland, RiverVest accesses forward-thinking research and clinical expertise at leading institutions across the country to found and fund biopharma and medical device companies.

Established in 2000, RiverVest has raised five core funds and invested in 61 portfolio companies, 19 of which it founded. Currently, 31 commercial products from RiverVest-backed companies are on the market, treating patients. For more information, please visit rivervest.com.

###

Media Contact

Derek Rapp

RiverVest Managing Director

314-726-6700

drapp@rivervest.com